Nomura Asset Management CO LTD Ironwood Pharmaceuticals Inc Transaction History

Nomura Asset Management CO LTD

6 transactions

Quarter	Operation	Price Per share	shares change
Q4 2018 Feb 12, 2019	SELL	$7.8 - $16.13 $0 - $0	0 Closed
Q3 2018 Nov 07, 2018	BUY	$14.31 - $17.65 $0 - $0	0 New
Q2 2018 Aug 03, 2018	BUY	$11.83 - $16.2 $0 - $0	0 New
Q1 2018 May 14, 2018	BUY	$11.13 - $13.63 $0 - $0	0 New
Q4 2017 Feb 14, 2018	BUY	$12.16 - $14.58 $0 - $0	0 New
Q3 2017 Nov 13, 2017	BUY	$12.07 - $14.87 $0 - $0	0

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $527M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.